lobbying_activities: 1693950

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1693950	53c42e80-b24c-4e6d-b737-70b8b1306145	Q2	GARY BUEHLER	401103724	TEVA PHARMACEUTICALS USA, INC.	2015	second_quarter	PHA	Section 505(b)(2) new drug applications and exclusivity period.	HOUSE OF REPRESENTATIVES,SENATE	10000		0	0	2015-07-13T16:52:07.160000-04:00